參考資料
1. Lipsi R, Mazzola D, Caminati A, et al. Severe idiopathic pulmonary fibrosis: A clinical approach. Eur J Intern Med. 2018;50:20–27.
2. Holtze C, Flaherty K, Kreuter M, et al. Healthcare utilisation and costs in the diagnosis and treatment of progressive-fibrosing interstitial lung diseases. Eur Respir Rev. 2018;27(150):180078.
3. Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2011;183(6):788–824.
4. Richeldi L, Varone F, Bergna M, et al. Pharmacological management of progressive-fibrosing interstitial lung diseases: a review of the current evidence. Eur Respir Rev. 2018;27(150):180074.